Skip to main content
. 2020 Aug 17;22(10):484–496. doi: 10.1016/j.neo.2020.07.003

Fig. 1.

Fig. 1

Effects of enzalutamide on uterine weights at 8- and 16-week timepoints. (A) Summary of study design. (B) Boxplots of individual uterine:body weight ratios. Circles represent outliers that are >1.5 box-lengths beyond the median. Statistical analysis comparing mean ratios for each treatment group and each timepoint performed by one-way ANOVA with post-hoc Bonferroni testing.